Gland Pharma Limited
Societe Generale bought 4 lakh shares of Gland Pharma for ₹113.06 Cr at ₹2826.60 apiece in a block deal.
A vertically integrated injectable-focused pharmaceutical company, Gland Pharma develops, manufactures, and markets complex injectables for global markets across the United States, Europe, Canada, Australia, and India. Established in Hyderabad in 1978, the company operates on a business-to-business model and serves customers in over 60 countries worldwide. Known for its expertise in complex injectable formulations, it maintains a strong presence across the value chain. Gland Pharma is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
French global investment bank with around EUR 1.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.